id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0007-0008,FDA,FDA-2002-P-0007,Letter from FDA DDM to The Weinberg Group Inc.,Other,Acknowledgement Letter/Receipt,2004-06-02T04:00:00Z,2004,6,,,2024-08-26T18:24:50Z,,0,0,090000648048743a
FDA-2002-P-0007-0004,FDA,FDA-2002-P-0007,Acknowledgement Letter from FDA DDM to The Weinberg Group Inc.,Other,Acknowledgement Letter/Receipt,2004-06-02T04:00:00Z,2004,6,,,2024-08-26T18:17:02Z,,0,0,090000648048742f
FDA-2002-P-0007-0005,FDA,FDA-2002-P-0007,Attachment 1  Cefuroxime Axetil Tablets for Oral Suspension [The Weinberg Group Inc. PRC 1),Supporting & Related Material,Background Material,2004-06-02T04:00:00Z,2004,6,,,2024-08-26T18:45:47Z,,0,0,0900006480487432
FDA-2002-P-0007-0006,FDA,FDA-2002-P-0007,"Attachment 2   ""Madlon-Kay, D.J and Mosch, F.S. D- Liquid Medication Dosing Errors"" The Weinberg Group Inc.",Supporting & Related Material,Background Material,2004-06-02T04:00:00Z,2004,6,,,2024-08-26T18:46:21Z,,0,0,0900006480487435
FDA-2002-P-0007-0007,FDA,FDA-2002-P-0007,SEE FDA-2002-P-0007-0004,Other,,2004-06-02T00:00:00Z,2004,6,,,2011-01-14T20:19:11Z,,0,1,0900006480487437
FDA-2002-P-0007-0003,FDA,FDA-2002-P-0007,"Petition Denial from FDA CDER to The Weinberg Group, Inc.",Other,PDN-Petition Denial,2004-05-04T04:00:00Z,2004,5,,,2024-08-26T17:53:09Z,,0,0,0900006480487428
FDA-2002-P-0007-0002,FDA,FDA-2002-P-0007,Interim Response to The Weinberg Group Inc (CP1),Other,LET-Letter,2004-02-05T05:00:00Z,2004,2,,,2024-08-26T17:51:54Z,,0,0,0900006480487423